Cytoreductive nephrectomy and exposure to sunitinib – a post hoc analysis of the Immediate Surgery or Surgery After Sunitinib Malate in Treating Patients With Metastatic Kidney Cancer (SURTIME) trial

TY - JOUR

T1 - Cytoreductive nephrectomy and exposure to sunitinib – a post hoc analysis of the Immediate Surgery or Surgery After Sunitinib Malate in Treating Patients With Metastatic Kidney Cancer (SURTIME) trial

N1 - Publisher Copyright: © 2021 The Authors BJU International © 2021 BJU International.

PY - 2022/7

Y1 - 2022/7

KW - #KidneyCancer

KW - #kcsm

KW - #uroonc

KW - cytoreductive nephrectomy

KW - deferred

KW - immediate

KW - renal cell carcinoma

KW - sunitinib

KW - survival

UR - http://www.scopus.com/inward/record.url?scp=85120573848&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85120573848&partnerID=8YFLogxK

U2 - 10.1111/bju.15625

DO - 10.1111/bju.15625

M3 - Article

AN - SCOPUS:85120573848

SN - 1464-4096

VL - 130

SP - 68

EP - 75

JO - BJU International

JF - BJU International

IS - 1

ER -